College Statement on the FAD from NICE following the STA process on Fluocinolone Acetonide for treatment of chronic DMO where there is inadequate response to prior therapy
3 December 2012
College Statement on the Final Appraisal Document (FAD) from NICE following the process on Fluocinolone Acetonide (Iluvien, Alimera Sciences) for treatment of chronic diabetic macular oedema where there is inadequate response to prior therapy